0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Equine Pharmaceuticals and Supplements Market Research Report 2026
Published Date: 2026-03-05
|
Report Code: QYRE-Auto-34V6752
Home | Market Reports | Pets & Animals| Animal Products & Services| Pet Food & Supplies
China Equine Pharmaceuticals and Supplements Market Report Forecast 2021 2027
BUY CHAPTERS

Global Equine Pharmaceuticals and Supplements Market Research Report 2026

Code: QYRE-Auto-34V6752
Report
2026-03-05
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Equine Pharmaceuticals and Supplements Market Size

The global Equine Pharmaceuticals and Supplements market was valued at US$ 1304 million in 2025 and is anticipated to reach US$ 1766 million by 2032, at a CAGR of 4.5% from 2026 to 2032.

Equine Pharmaceuticals and Supplements Market

Equine Pharmaceuticals and Supplements Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Equine Pharmaceuticals and Supplements competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.
This report delivers a comprehensive overview of the global Equine Pharmaceuticals and Supplements market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Equine Pharmaceuticals and Supplements. The Equine Pharmaceuticals and Supplements market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Equine Pharmaceuticals and Supplements market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Equine Pharmaceuticals and Supplements manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Equine Pharmaceuticals and Supplements Market Report

Report Metric Details
Report Name Equine Pharmaceuticals and Supplements Market
Accounted market size in 2025 US$ 1304 million
Forecasted market size in 2032 US$ 1766 million
CAGR 4.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Pharmaceuticals
  • Supplements
by Application
  • Thoroughbred Horse
  • Other Types of Horses
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Equine Pharmaceuticals and Supplements manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Equine Pharmaceuticals and Supplements sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Equine Pharmaceuticals and Supplements Market growing?

Ans: The Equine Pharmaceuticals and Supplements Market witnessing a CAGR of 4.5% during the forecast period 2026-2032.

What is the Equine Pharmaceuticals and Supplements Market size in 2032?

Ans: The Equine Pharmaceuticals and Supplements Market size in 2032 will be US$ 1766 million.

What is the market share of major companies in Equine Pharmaceuticals and Supplements Market?

Ans: Global top three manufacturers hold a share over 50%.

What is the Equine Pharmaceuticals and Supplements Market share by type?

Ans: In terms of product, Pharmaceuticals is the largest segment, with a share about 80%.

Who are the main players in the Equine Pharmaceuticals and Supplements Market report?

Ans: The main players in the Equine Pharmaceuticals and Supplements Market are Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude

What are the Application segmentation covered in the Equine Pharmaceuticals and Supplements Market report?

Ans: The Applications covered in the Equine Pharmaceuticals and Supplements Market report are Thoroughbred Horse, Other Types of Horses

What are the Type segmentation covered in the Equine Pharmaceuticals and Supplements Market report?

Ans: The Types covered in the Equine Pharmaceuticals and Supplements Market report are Pharmaceuticals, Supplements

1 Equine Pharmaceuticals and Supplements Market Overview
1.1 Product Definition
1.2 Equine Pharmaceuticals and Supplements by Type
1.2.1 Global Equine Pharmaceuticals and Supplements Market Value by Type: 2025 vs 2032
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Equine Pharmaceuticals and Supplements by Application
1.3.1 Global Equine Pharmaceuticals and Supplements Market Value by Application: 2025 vs 2032
1.3.2 Thoroughbred Horse
1.3.3 Other Types of Horses
1.4 Global Equine Pharmaceuticals and Supplements Market Size Estimates and Forecasts
1.4.1 Global Equine Pharmaceuticals and Supplements Revenue 2021–2032
1.4.2 Global Equine Pharmaceuticals and Supplements Sales 2021–2032
1.4.3 Global Equine Pharmaceuticals and Supplements Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Equine Pharmaceuticals and Supplements Market Competition by Manufacturers
2.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2021–2026)
2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Equine Pharmaceuticals and Supplements, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Product Types and Applications
2.7 Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Date of Entry into the Industry
2.8 Global Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
2.8.1 Global Equine Pharmaceuticals and Supplements Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Equine Pharmaceuticals and Supplements Players Market Share by Revenue
2.8.3 Global Equine Pharmaceuticals and Supplements Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Equine Pharmaceuticals and Supplements Market Scenario by Region
3.1 Global Equine Pharmaceuticals and Supplements Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2021–2032
3.2.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2021–2026
3.2.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2027–2032
3.3 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2021–2032
3.3.1 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2021–2026
3.3.2 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2027–2032
3.4 North America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
3.4.1 North America Equine Pharmaceuticals and Supplements Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Equine Pharmaceuticals and Supplements Sales by Country (2021–2032)
3.4.3 North America Equine Pharmaceuticals and Supplements Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
3.5.1 Europe Equine Pharmaceuticals and Supplements Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Equine Pharmaceuticals and Supplements Sales by Country (2021–2032)
3.5.3 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Equine Pharmaceuticals and Supplements Market Facts & Figures by Region
3.6.1 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2021–2032)
3.6.3 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
3.7.1 Latin America Equine Pharmaceuticals and Supplements Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Equine Pharmaceuticals and Supplements Sales by Country (2021–2032)
3.7.3 Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
3.8.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2021–2032)
3.8.3 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2021–2032)
4.1.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2021–2026)
4.1.2 Global Equine Pharmaceuticals and Supplements Sales by Type (2027–2032)
4.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021–2032)
4.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2021–2032)
4.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Type (2021–2026)
4.2.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2027–2032)
4.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021–2032)
4.3 Global Equine Pharmaceuticals and Supplements Price by Type (2021–2032)
5 Segment by Application
5.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2021–2032)
5.1.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2021–2026)
5.1.2 Global Equine Pharmaceuticals and Supplements Sales by Application (2027–2032)
5.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021–2032)
5.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2021–2032)
5.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Application (2021–2026)
5.2.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2027–2032)
5.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021–2032)
5.3 Global Equine Pharmaceuticals and Supplements Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Company Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Bayer Animal Health
6.4.1 Bayer Animal Health Company Information
6.4.2 Bayer Animal Health Description and Business Overview
6.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
6.4.5 Bayer Animal Health Recent Developments/Updates
6.5 Elanco Animal Health
6.5.1 Elanco Animal Health Company Information
6.5.2 Elanco Animal Health Description and Business Overview
6.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
6.5.5 Elanco Animal Health Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Company Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 CEVA
6.7.1 CEVA Company Information
6.7.2 CEVA Description and Business Overview
6.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
6.7.5 CEVA Recent Developments/Updates
6.8 Virbac
6.8.1 Virbac Company Information
6.8.2 Virbac Description and Business Overview
6.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
6.8.5 Virbac Recent Developments/Updates
6.9 Norbrook Equine
6.9.1 Norbrook Equine Company Information
6.9.2 Norbrook Equine Description and Business Overview
6.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
6.9.5 Norbrook Equine Recent Developments/Updates
6.10 Kyoritsu Seiyaku
6.10.1 Kyoritsu Seiyaku Company Information
6.10.2 Kyoritsu Seiyaku Description and Business Overview
6.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
6.10.5 Kyoritsu Seiyaku Recent Developments/Updates
6.11 Vetoquinol
6.11.1 Vetoquinol Company Information
6.11.2 Vetoquinol Description and Business Overview
6.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
6.11.5 Vetoquinol Recent Developments/Updates
6.12 Protexin Healthcare
6.12.1 Protexin Healthcare Company Information
6.12.2 Protexin Healthcare Description and Business Overview
6.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
6.12.5 Protexin Healthcare Recent Developments/Updates
6.13 Audevard
6.13.1 Audevard Company Information
6.13.2 Audevard Description and Business Overview
6.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
6.13.5 Audevard Recent Developments/Updates
6.14 Ouro Fino Saude
6.14.1 Ouro Fino Saude Company Information
6.14.2 Ouro Fino Saude Description and Business Overview
6.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
6.14.5 Ouro Fino Saude Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
7.2 Equine Pharmaceuticals and Supplements Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Equine Pharmaceuticals and Supplements Production Mode & Process Analysis
7.4 Equine Pharmaceuticals and Supplements Sales and Marketing
7.4.1 Equine Pharmaceuticals and Supplements Sales Channels
7.4.2 Equine Pharmaceuticals and Supplements Distributors
7.5 Equine Pharmaceuticals and Supplements Customer Analysis
8 Equine Pharmaceuticals and Supplements Market Dynamics
8.1 Equine Pharmaceuticals and Supplements Industry Trends
8.2 Equine Pharmaceuticals and Supplements Market Drivers
8.3 Equine Pharmaceuticals and Supplements Market Challenges
8.4 Equine Pharmaceuticals and Supplements Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Equine Pharmaceuticals and Supplements Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Equine Pharmaceuticals and Supplements Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Equine Pharmaceuticals and Supplements Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Equine Pharmaceuticals and Supplements Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Equine Pharmaceuticals and Supplements, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Product Types and Applications
 Table 12. Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Equine Pharmaceuticals and Supplements Companies by Tier (Tier 1, Tier 2, Tier 3), based on Equine Pharmaceuticals and Supplements Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Equine Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Equine Pharmaceuticals and Supplements Sales by Region (K Units), 2021–2026
 Table 18. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2021–2026)
 Table 19. Global Equine Pharmaceuticals and Supplements Sales by Region (K Units), 2027–2032
 Table 20. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2027–2032)
 Table 21. Global Equine Pharmaceuticals and Supplements Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2021–2026)
 Table 23. Global Equine Pharmaceuticals and Supplements Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2027–2032)
 Table 25. North America Equine Pharmaceuticals and Supplements Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Equine Pharmaceuticals and Supplements Sales by Country (K Units), 2021–2026
 Table 27. North America Equine Pharmaceuticals and Supplements Sales by Country (K Units), 2027–2032
 Table 28. North America Equine Pharmaceuticals and Supplements Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Equine Pharmaceuticals and Supplements Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Equine Pharmaceuticals and Supplements Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Equine Pharmaceuticals and Supplements Sales by Country (K Units), 2021–2026
 Table 32. Europe Equine Pharmaceuticals and Supplements Sales by Country (K Units), 2027–2032
 Table 33. Europe Equine Pharmaceuticals and Supplements Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Equine Pharmaceuticals and Supplements Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Equine Pharmaceuticals and Supplements Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Equine Pharmaceuticals and Supplements Sales by Country (K Units), 2021–2026
 Table 42. Latin America Equine Pharmaceuticals and Supplements Sales by Country (K Units), 2027–2032
 Table 43. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2021–2026)
 Table 51. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2027–2032)
 Table 52. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021–2026)
 Table 53. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2027–2032)
 Table 54. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021–2026)
 Table 57. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2027–2032)
 Table 58. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2021–2026)
 Table 61. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2027–2032)
 Table 62. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021–2026)
 Table 63. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2027–2032)
 Table 64. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021–2026)
 Table 67. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2027–2032)
 Table 68. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Application (2027–2032)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Merck Animal Health Company Information
 Table 76. Merck Animal Health Description and Business Overview
 Table 77. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Merck Animal Health Equine Pharmaceuticals and Supplements Product
 Table 79. Merck Animal Health Recent Developments/Updates
 Table 80. Zoetis Company Information
 Table 81. Zoetis Description and Business Overview
 Table 82. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Zoetis Equine Pharmaceuticals and Supplements Product
 Table 84. Zoetis Recent Developments/Updates
 Table 85. Bayer Animal Health Company Information
 Table 86. Bayer Animal Health Description and Business Overview
 Table 87. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Bayer Animal Health Equine Pharmaceuticals and Supplements Product
 Table 89. Bayer Animal Health Recent Developments/Updates
 Table 90. Elanco Animal Health Company Information
 Table 91. Elanco Animal Health Description and Business Overview
 Table 92. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Elanco Animal Health Equine Pharmaceuticals and Supplements Product
 Table 94. Elanco Animal Health Recent Developments/Updates
 Table 95. Dechra Veterinary Products Company Information
 Table 96. Dechra Veterinary Products Description and Business Overview
 Table 97. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product
 Table 99. Dechra Veterinary Products Recent Developments/Updates
 Table 100. CEVA Company Information
 Table 101. CEVA Description and Business Overview
 Table 102. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. CEVA Equine Pharmaceuticals and Supplements Product
 Table 104. CEVA Recent Developments/Updates
 Table 105. Virbac Company Information
 Table 106. Virbac Description and Business Overview
 Table 107. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Virbac Equine Pharmaceuticals and Supplements Product
 Table 109. Virbac Recent Developments/Updates
 Table 110. Norbrook Equine Company Information
 Table 111. Norbrook Equine Description and Business Overview
 Table 112. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Norbrook Equine Equine Pharmaceuticals and Supplements Product
 Table 114. Norbrook Equine Recent Developments/Updates
 Table 115. Kyoritsu Seiyaku Company Information
 Table 116. Kyoritsu Seiyaku Description and Business Overview
 Table 117. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product
 Table 119. Kyoritsu Seiyaku Recent Developments/Updates
 Table 120. Vetoquinol Company Information
 Table 121. Vetoquinol Description and Business Overview
 Table 122. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Vetoquinol Equine Pharmaceuticals and Supplements Product
 Table 124. Vetoquinol Recent Developments/Updates
 Table 125. Protexin Healthcare Company Information
 Table 126. Protexin Healthcare Description and Business Overview
 Table 127. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Protexin Healthcare Equine Pharmaceuticals and Supplements Product
 Table 129. Protexin Healthcare Recent Developments/Updates
 Table 130. Audevard Company Information
 Table 131. Audevard Description and Business Overview
 Table 132. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Audevard Equine Pharmaceuticals and Supplements Product
 Table 134. Audevard Recent Developments/Updates
 Table 135. Ouro Fino Saude Company Information
 Table 136. Ouro Fino Saude Description and Business Overview
 Table 137. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product
 Table 139. Ouro Fino Saude Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Equine Pharmaceuticals and Supplements Distributors List
 Table 143. Equine Pharmaceuticals and Supplements Customers List
 Table 144. Equine Pharmaceuticals and Supplements Market Trends
 Table 145. Equine Pharmaceuticals and Supplements Market Drivers
 Table 146. Equine Pharmaceuticals and Supplements Market Challenges
 Table 147. Equine Pharmaceuticals and Supplements Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Equine Pharmaceuticals and Supplements
 Figure 2. Global Equine Pharmaceuticals and Supplements Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Equine Pharmaceuticals and Supplements Market Share by Type: 2025 & 2032
 Figure 4. Pharmaceuticals Product Picture
 Figure 5. Supplements Product Picture
 Figure 6. Global Equine Pharmaceuticals and Supplements Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Equine Pharmaceuticals and Supplements Market Share by Application: 2025 & 2032
 Figure 8. Thoroughbred Horse
 Figure 9. Other Types of Horses
 Figure 10. Global Equine Pharmaceuticals and Supplements Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Equine Pharmaceuticals and Supplements Market Size (US$ Million), 2021–2032
 Figure 12. Global Equine Pharmaceuticals and Supplements Sales (K Units), 2021–2032
 Figure 13. Global Equine Pharmaceuticals and Supplements Average Price (USD/Unit), 2021–2032
 Figure 14. Equine Pharmaceuticals and Supplements Report Years Considered
 Figure 15. Equine Pharmaceuticals and Supplements Sales Share by Manufacturers in 2025
 Figure 16. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Equine Pharmaceuticals and Supplements Players: Market Share by Revenue in Equine Pharmaceuticals and Supplements in 2025
 Figure 18. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Equine Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021–2032)
 Figure 21. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2021–2032)
 Figure 22. U.S. Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021–2032)
 Figure 25. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2021–2032)
 Figure 33. China Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Taiwan Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Philippines Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. U.A.E Equine Pharmaceuticals and Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Equine Pharmaceuticals and Supplements by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Equine Pharmaceuticals and Supplements by Type (2021–2032)
 Figure 55. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Equine Pharmaceuticals and Supplements by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Equine Pharmaceuticals and Supplements by Application (2021–2032)
 Figure 58. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Application (2021–2032)
 Figure 59. Equine Pharmaceuticals and Supplements Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc